Risk factors for Azheimer's disease during aging. Impacts of glucose/energy metabolism

Journal of Neural Transmission, Supplement

Volumn , Issue 54, 1998, Pages 187-194

  Hoyer, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; INSULIN; TAU PROTEIN; GLUCOSE;

AGING; ALZHEIMER DISEASE; DISEASE ASSOCIATION; ENERGY METABOLISM; GLUCOSE METABOLISM; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; GROWTH, DEVELOPMENT AND AGING; METABOLISM; NERVE CELL; PHYSIOLOGY;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; ENERGY METABOLISM; GLUCOSE; HUMANS; NEURONS; RISK FACTORS;

EID: 0032239618     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-7508-8_18     Document Type: Review

References (43)

1. Bodovitzs S, Kelin WL (1996) Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J Biol Chem 271: 4436-4440
2. Bowen DM (1984) Cellular aging: selective vulnerability of cholinergic neurons in human brain. Monogr Dev Biol 17: 42-59
3. Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A, Migheli A, Stern D (1993) Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143: 1699-1712
4. Cai XD, Golde TE, Younkin SG (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259: 514-519
5. Drachman DA, Noffsinger D, Sahakian BJ, Kurdziel S, Fleming P (1980) Aging, memory and the cholinergic system: a study of dichotic listening. Neurobiol Aging 1: 39-43
6. Dutschke K, Nitsch RM, Hoyer S (1994) Short-term mental activation accelerates the age-related decline of high-energy phosphates in rat cerebral cortex. Arch Gerontol Geriatr 19: 43-51
7. Erecinska M, Silver IA (1989) ATP and brain function. J Cereb Blood Flow Metab 9: 2-19
8. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO (1989) Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. J Am Med Assoc 262: 2551-2556
9. Frölich L, Blum-Degen D, Hoyer S, Beckmann H, Riederer P (1997) Insulin, insulin receptors and IGF-I receptors in post-mortem human brain in ageing and in dementia of Alzheimer type. In: Iqbal K, Winblad B, Nishimura T, Takeda M, Wisniewski HM (eds) Alzheimer's disease: biology, diagnosis and therapeutics. Wiley, Chichester, pp 457-465
10. Gabuzda D, Buciglio J, Chen LB, Matsudaira P, Yankner BA (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269: 13623-13628
11. Gibson GE, Blass JP (1976) Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem 27: 37-42
12. Gottfries CG (1985) Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86: 245-252
13. Harik SI, McCracken KA (1986) Age-related increase in presynaptic noradrenergic markers of the rat cerebral cortex. Brain Res 381: 125-130
14. Henneberg N, Hoyer S (1995) Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch Gerontol Geriatr 21: 63-74
15. Hoyer S (1985) The effect of age on glucose and energy metabolism in brain cortex of rats. Arch Gerontol Geriatr 4: 193-203
16. Hoyer S (1986) Senile dementia and Alzheimer's disease: brain blood flow and metabolism. Progr Neuropsychopharmacol Biol Psychiatry 10: 447-478
17. Hoyer S (1992) Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol Chem Neuropathol 16: 207-224
18. Hoyer S (1995) Age-related changes in cerebral oxidative metabolism. Implications for drug therapy. Drugs Aging 6: 210-218
19. Hoyer S (1997) Models of Alzheimer's disease: cellular and molecular aspects. J Neural Transm [Suppl] 49: 11-21
20. Ida Y, Tanaka M, Kohno Y, Nakagawa R, Iimori K, Tsuda A, Hoaki Y, Nagasaki N (1982) Effects of age and stress on regional noradrenaline metabolism in the rat brain. Neurobiol Aging 3: 233-236
21. Igbavboa U, Avdulov A, Schroeder F, Wood WG (1996) Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J Neurochem 66: 1717-1725
22. Li JJ, Surini M, Catsicas S, Kawashima E, Bouras C (1995) Age-dependent accumulation of advanced glycosylation end products in human neurons. Neurobiol Aging 16: 69-76
23. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NPV, Meaney MJ (1994) Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14: 2893-2903
24. 2+/calmodulin-dependent protein kinase II in rat hippocampus. Eur J Pharmacol 309: 311-315
25. Nadiv O, Shinitzky M, Manu H, Hecht D, Robert CT, Le Roith D, Zick Y (1994) Elevated protein tyrosine phosphatase activity and increase membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats. Biochem J 298: 443-450
26. Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A (1995) Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. Br J Med 310: 970-973
27. Petryniak MA, Wurtman RJ, Slack BE (1996) Elevated intracellular calcium concentration increases secretory processing of the amyloid precursor protein by a tyrosine-phosphorylation-dependent mechanism. Biochem J 320: 957-963
28. Plaschke K, Müller D, Hoyer S (1996) Effects of adrenalectomy and corticosterone substitution on glucose and energy metabolism in rat brain. J Neural Transm 103: 89-100
29. Racchi M, Baetta R, Salvietti N, Ianna P, Franceschini G, Paoletti R, Fumagalli R, Govoni S, Trabucchi M, Soma M (1997) Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J 322: 893-898
30. Roberts EL jr, Sick TJ (1996) Aging impairs regulation of intracellular pH in rat hippocampal slices. Brain Res 735: 339-342
31. Roder HM, Ingram VM (1991) Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios. J Neurosci 11: 3325-3343
32. Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Res 7: 284-301
33. Seksek O, Biwersi J, Verkman AS (1995) Direct measurement of trans-Golgi pH in living cells and regulation by second messengers. J Biol Chem 270: 4967-4970
34. 14C) glucose by tissue prisms from human neocortex. Biochem J 196: 867-876
35. Stephens DJ, Austen BM (1986) Metabolites of the β-amyloid precursor protein generated by β-secretase localise to the trans-Golgi network and late endosome in 293 cells. J Neurosci Res 46: 211-225
36. Storandt M, Bäkman L, Baltes MM, Blass JP, Braak H, Gutzmann H, Hauw JJ, Hoyer S, Jorm AF, Kauss J, Kliegl R, Mountjoy CQ (1988) Relationships of normal aging and dementing disease in later life. In: Henderson AS, Henderson JH (eds) Etiology of dementia of Alzheimer's type. Wiley, Chichester, pp 231-239
37. Swaab DF, Raadsheer FC, Endert EF, Hofman MA, Kamphorst W, Ravid R (1994) Increases of cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid. J Neuroendocrinol 6: 681-687
38. Verde C, Pascale MC, Martire G, Lotti LV, Torrisi MR, Helenius A, Bonatti S (1995) Effect of ATP depletion and DTT on the transport of membrane proteins from the endoplasmic reticulum and the intermediate compartment to the Golgi complex. Eur J Cell Biol 67: 267-274
39. Vlassara H, Bucala R, Striker L (1994) Biology of disease. Pathogenetic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70: 138-151
40. Wallace WC, Lieberburg I, Schenk D, Vigo-Pelfrey C, Davis KL, Haroutunian V (1995) Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats. J Neurosci 15: 4896-4905
41. Wild-Bode C, Yamazaki T, Capell A, Leimert U, Steiner H, Ihara Y, Haass C (1997) Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42. J Biol Chem 272
42. Wu Y, Sun FF, Tong DM, Taylor BM (1996) Changes in membrane-properties during energy depletion-induced cell injury studied with fluorescence microscopy. Biophys J 71: 91-100
43. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691